In this episode, Samuel Arbesman speaks with Lawrence Lundy-Bryan, a partner at the venture capital firm Lunar Ventures who specializes in researching the landscape of cutting-edge technological advances. Lawrence has been examining technologies as part of a project called the State of the Future, providing analyses into a large number of new technological developments.And the current state of AI is freaking him out. In a recent essay titled "data-driven VC is over," Lawrence looks at how the new AI research tool Deep Research basically can do everything he used to do. This has prompted Lawrence to think about his work, and work and meaning more broadly, which he has also explored in further essays.Samuel and Lawrence discuss the nature of research in the world of venture capital and the shock of using Deep Research. They examine how to think about AI when it takes away not only work you are good at, but something you enjoy and love doing. They talk about the future of venture capital in an age of research democratization and the role of secret knowledge, taste, and wisdom, as well as how people have responded to Lawrence's essay. They even explore broader future implications, including youth unemployment and how education might need to be rethought.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare